Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
We’re pleased to announce that our paper, “Humoral and T-Cell Responses to SARS-CoV-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab” was published today! We’re extremely proud and grateful to all of you who participated! Your contributions added to our scientific knowledge and understanding!
Read the full article here.